Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.40%148.08M | -15.46%144.88M | -22.94%131.6M | -9.96%623.02M | -22.68%130.68M | -16.91%150.18M | -3.11%171.37M | 3.32%170.79M | 15.21%691.94M | 14.49%169.01M |
| Cost of revenue | 1.50%109.1M | -14.63%105.86M | -20.31%96.65M | -8.24%444.54M | -20.61%91.77M | -14.82%107.49M | -0.08%124M | 2.26%121.27M | 16.08%484.47M | 12.34%115.59M |
| Gross profit | -8.68%38.98M | -17.63%39.02M | -29.40%34.96M | -13.97%178.49M | -27.17%38.91M | -21.74%42.69M | -10.26%47.37M | 6.01%49.52M | 13.24%207.47M | 19.43%53.43M |
| Operating expense | -17.88%17.44M | 38.35%21.1M | -26.33%13.63M | 7.56%85.02M | -20.71%17.52M | 29.70%21.24M | 7.73%15.25M | 37.51%18.5M | 38.84%79.05M | 52.07%22.1M |
| Selling and administrative expenses | -29.92%21.03M | 78.32%32M | -19.82%17.31M | -5.63%82.89M | -8.28%29.1M | 32.43%30.01M | -19.36%17.95M | -2.70%21.59M | 29.49%87.83M | 274.04%31.73M |
| -Selling and marketing expense | 45.22%2.38M | 25.82%2.39M | 1.93%2.65M | 1.68%9.41M | 61.17%3.28M | -42.78%1.64M | -15.46%1.9M | 23.02%2.6M | -7.12%9.26M | -6.64%2.03M |
| -General and administrative expense | -34.27%18.65M | 84.52%29.62M | -22.80%14.66M | -6.49%73.48M | -13.03%25.82M | 43.33%28.37M | -19.80%16.05M | -5.40%18.99M | 35.80%78.58M | 370.93%29.69M |
| Other operating expenses | 60.36%1.16M | -179.20%-537K | -115.52%-90K | 714.82%3.22M | 115,800.00%2.31M | 1,148.28%724K | 409.77%678K | 480.00%580K | 88.25%-524.47K | 99.96%-2K |
| Total other operating income | -49.96%4.75M | 207.17%10.37M | -2.15%3.59M | -86.83%1.09M | 44.35%13.89M | 49.67%9.5M | -59.01%3.38M | -58.48%3.67M | 28.45%8.26M | 188.65%9.62M |
| Operating profit | 0.42%21.55M | -44.22%17.92M | -31.24%21.33M | -27.22%93.46M | -31.72%21.39M | -43.81%21.45M | -16.85%32.12M | -6.74%31.01M | 1.70%128.42M | 3.73%31.33M |
| Net non-operating interest income (expenses) | -1.30%12.79M | 74.32%12.96M | ||||||||
| Non-operating interest income | ---- | ---- | ---- | -1.30%12.79M | ---- | ---- | ---- | ---- | 72.30%12.96M | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 1,268.97%678K | -793.33%-268K | -248.65%-774K | -1,514.32%-556.75K | -488.10%-247K | 90.99%-58K | 90.74%-30K | -121.12%-222K | 102.41%39.37K | 94.55%-42K |
| Special income (charges) | -284.37K | 0 | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --284.37K | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 3.87%22.22M | -45.00%17.65M | -33.26%20.55M | -25.46%105.42M | -32.42%21.14M | -43.00%21.4M | -16.22%32.09M | -10.24%30.79M | 7.07%141.43M | -15.28%31.28M |
| Income tax | -995.43%-1.76M | -28.78%334K | -35.05%328K | 61.15%1.54M | 122.17%364K | -77.09%197K | -57.09%469K | -21.22%505K | -38.29%952.6K | -267.62%-1.64M |
| Net income | 13.15%23.99M | -45.24%17.32M | -33.23%20.22M | -26.05%103.88M | -36.89%20.78M | -42.20%21.2M | -15.02%31.62M | -10.03%30.29M | 7.61%140.47M | -8.40%32.93M |
| Net income continuous operations | 13.15%23.99M | -45.24%17.32M | -33.23%20.22M | -26.05%103.88M | -36.89%20.78M | -42.20%21.2M | -15.02%31.62M | -10.03%30.29M | 7.61%140.47M | -8.40%32.93M |
| Noncontrolling interests | -27.05%6.88M | -51.34%5.7M | -34.40%7.16M | -24.68%38.67M | -45.87%6.62M | -28.47%9.43M | -13.53%11.72M | -11.94%10.91M | 6.70%51.35M | -7.42%12.22M |
| Net income attributable to the company | 45.33%17.11M | -41.65%11.61M | -32.57%13.07M | -26.83%65.21M | -31.59%14.16M | -49.89%11.77M | -15.87%19.9M | -8.92%19.38M | 8.14%89.13M | -8.97%20.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 45.33%17.11M | -41.65%11.61M | -32.57%13.07M | -26.83%65.21M | -31.59%14.16M | -49.89%11.77M | -15.87%19.9M | -8.92%19.38M | 8.14%89.13M | -8.97%20.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 45.18%0.0241 | -41.79%0.0163 | -32.35%0.0184 | 2,447.25%3.1917 | -31.62%0.0199 | -49.70%0.0166 | -15.92%0.028 | -9.03%0.0272 | 8.20%0.1253 | -8.78%0.0291 |
| Diluted earnings per share | 45.18%0.0241 | -41.79%0.0163 | -32.35%0.0184 | 2,447.25%3.1917 | -31.62%0.0199 | -49.70%0.0166 | -15.92%0.028 | -9.03%0.0272 | 8.20%0.1253 | -8.78%0.0291 |
| Dividend per share | 0 | 0 | 0 | 0.00%0.02 | 0 | 0.00%0.02 | 0 | 0 | 0.00%0.02 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.